Mucinous cystadenocarcinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Risk Factors== | ==Risk Factors== | ||
* [[Obesity]] | * [[Obesity]] | ||
* [[Menopause|Post menopausal]] women on [[hormone replacement therapy]] | * [[Menopause|Post menopausal]] women on [[hormone replacement therapy]] | ||
*[[Menopause|Perimenopausal]] or [[Menopause|post-menopausal]] state<ref name="pmid11075847">{{cite journal |vauthors=Lee KR, Scully RE |title=Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei' |journal=Am. J. Surg. Pathol. |volume=24 |issue=11 |pages=1447–64 |date=November 2000 |pmid=11075847 |doi= |url=}}</ref> | *[[Menopause|Perimenopausal]] or [[Menopause|post-menopausal]] state<ref name="pmid11075847">{{cite journal |vauthors=Lee KR, Scully RE |title=Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei' |journal=Am. J. Surg. Pathol. |volume=24 |issue=11 |pages=1447–64 |date=November 2000 |pmid=11075847 |doi= |url=}}</ref> | ||
*[[Smoking]] | *[[Smoking]] | ||
Revision as of 17:47, 10 September 2019
|
Mucinous cystadenocarcinoma Microchapters |
|
Differentiating Mucinous Cystadenocarcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mucinous cystadenocarcinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Mucinous cystadenocarcinoma risk factors |
|
Directions to Hospitals Treating Mucinous cystadenocarcinoma |
|
Risk calculators and risk factors for Mucinous cystadenocarcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]; Ammu Susheela, M.D. [3]
Overview
Common risk factors in the development of mucinous cystadenocarcinoma are obesity and post menopausal women on hormone replacement therapy and genetic predilection.
Risk Factors
- Obesity
- Post menopausal women on hormone replacement therapy
- Perimenopausal or post-menopausal state[1]
- Smoking
- KRAS mutation